These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2424091)

  • 1. Trial of specific antigen-mediated leukocyte adherence inhibition test in patients with chronic active hepatitis and hepatitis B carrier.
    Oh YI; Song SH; Kim WH; Cho KH; An JK; Ahn DS
    Korean J Intern Med; 1986 Jul; 1(2):158-65. PubMed ID: 3154610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study on plasma prostaglandin E2 levels in hepatitis B carriers and patients with chronic active hepatitis.
    Kim JH; Heo YS; Ahn KY; Lee YG; Kim DG; Ahn DS
    Korean J Intern Med; 1987 Jul; 2(2):170-5. PubMed ID: 3154830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of duck hepatitis B virus DNA replication by antiviral chemotherapy with ganciclovir-nalidixic acid.
    Wang Y; Luscombe C; Bowden S; Shaw T; Locarnini S
    Antimicrob Agents Chemother; 1995 Feb; 39(2):556-8. PubMed ID: 7726533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the replication of hepatitis B virus by the carbocyclic analogue of 2'-deoxyguanosine.
    Price PM; Banerjee R; Acs G
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8541-4. PubMed ID: 2813411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response rates.
    Thomas HC; Scully LJ; Lever AM; Yap I; Pignatelli M
    Infection; 1987; 15 Suppl 1():S26-31. PubMed ID: 2439462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antiviral agents on chronic hepatitis B. Analysis using Cox proportional hazard model.
    Takano S; Omata M; Yokosuka O; Imazeki F; Ohto M
    Dig Dis Sci; 1992 Nov; 37(11):1633-43. PubMed ID: 1425062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis.
    Rosina F; Saracco G; Lattore V; Quartarone V; Rizzetto M; Verme G; Trinchero P; Sansalvadore F; Smedile A
    Prog Clin Biol Res; 1987; 234():299-303. PubMed ID: 3628384
    [No Abstract]   [Full Text] [Related]  

  • 8. [Interferon treatment of chronic viral hepatitis].
    Pirovino M
    Ther Umsch; 1992 May; 49(5):302-9. PubMed ID: 1377840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cell function during interferon treatment of delta hepatitis.
    Actis GC; Maran E; Saracco G; Rosina F; Baldi M; Brunetto M
    Prog Clin Biol Res; 1987; 234():305-8. PubMed ID: 3628385
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of chronic viral hepatitis.
    de Man RA; Berk L; Schalm SW; Stijnen T
    Dig Dis; 1991; 9(1):17-35. PubMed ID: 1706968
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis B viral infection.
    Thomas HC
    Am J Med; 1988 Aug; 85(2A):135-40. PubMed ID: 3136648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches to the treatment of hepatitis B virus and delta-related liver disease.
    Thomas HC; Lever AM; Scully LJ; Pignatelli M
    Semin Liver Dis; 1986 Feb; 6(1):34-41. PubMed ID: 2424091
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.